Former President Donald Trump got an antibody Covid-19 treatment and an antiviral drug, but those therapies continue to be underused throughout the U.S.
The U.S. government wants the antibody products from Regeneron Pharmaceuticals Inc. and Eli Lilly and Co. to be prescribed more often, but it isn’t happening. Last month the administration allocated enough of them for 641,000 patients and noted only 25% of what was available was being used.
1. What treatments are available for Covid-19 patients?
Several products are authorized by the FDA to treat Covid-19 directly, but their usefulness varies based on the severity of the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.